(Q50891302)

24 March 2018

title

Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women. (English)

1 reference

24 March 2018

author

Simon N Young

7

1 reference

24 March 2018

author name string

Paul A Newhouse

1

1 reference

24 March 2018

Julie Dumas

2

1 reference

24 March 2018

Catherine Hancur-Bucci

3

1 reference

24 March 2018

Magdalena Naylor

4

1 reference

24 March 2018

Cynthia K Sites

5

1 reference

24 March 2018

Chawki Benkelfat

6

1 reference

24 March 2018

language of work or name

English

0 references

publication date

15 August 2007

1 reference

24 March 2018

published in

Neuropsychopharmacology

1 reference

24 March 2018

volume

33

1 reference

24 March 2018

issue

7

1 reference

24 March 2018

page(s)

1514-1527

1 reference

24 March 2018

Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

Effects of estrogen variation on neural correlates of emotional response inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estradiol and tryptophan depletion interact to modulate cognition in menopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogens and the hypothalamo-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity .

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Effect of estradiol implant on noradrenergic function and mood in menopausal subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Neuroactive steroids and seizure susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Neuropharmacology. Premenstrual steroids?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The effects of transdermal estradiol on the response to mental stress in postmenopausal women: a randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Risk for New Onset of Depression During the Menopausal Transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

New findings from non-linear longitudinal modelling of menopausal hormone changes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Acute tryptophan depletion in healthy young women with a family history of major affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

1 reference

7 January 2021

Associations of hormones and menopausal status with depressed mood in women with no history of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Acute tryptophan depletion in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Role of estrogen in the treatment of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen augments serotonergic activity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Effects of estrogen plus progestin on health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The effects of sex and hormonal status on the physiological response to acute psychosocial stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Effects on mood of acute phenylalanine/tyrosine depletion in healthy women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The effect of progestins on behavioral stress responses in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The hypothalamic-pituitary-adrenal axis and the female reproductive system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen actions throughout the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Mood symptoms and cognitive performance in women estrogen users and nonusers and men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Fear recognition across the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Perimenopause: The Complex Endocrinology of the Menopausal Transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen-serotonin interactions: implications for affective regulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Lack of effects of acute estradiol on mood in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen replacement in perimenopause-related depression: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Efficacy of Citalopram as a Monotherapy or as an Adjunctive Treatment to Estrogen Therapy for Perimenopausal and Postmenopausal Women With Depression and Vasomotor Symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Hormones and mood: from menarche to menopause and beyond

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Postmenopausal estrogen therapy and depressive symptoms in older women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Tryptophan depletion causes a rapid lowering of mood in normal males

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

A meta-analysis of the effect of hormone replacement therapy upon depressed mood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301530

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301530

1 reference

24 March 2018

1 reference

24 March 2018